Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Development of a mRNA Lipid Nanoparticle (mRNA-LNP) Cancer Vaccine to Prevent Leukemia Relapse after Stem Cell Transplant

Anson Snow, Lin Lin, Sally A. Hunsucker, Ying Wang, Rihe Liu, Paul M. Armistead

Blood (2022) 140 (Supplement 1): 7382–7383.

https://doi.org/10.1182/blood-2022-160218

Published: 2022

Journal Articles

Associations of Minor Histocompatibility Antigens with Clinical Outcomes Following Allogeneic Hematopoietic Cell Transplantation

Othmane Jadi, Hancong Tang, Kelly Shea Olsen, Steven Vensko, Qianqian Zhu, Yiwen Wang, Christopher A. Haiman, Loreall Pooler, Xin Sheng, Guy Brock, Amy Webb, Marcelo C Pasquini, Philip L. McCarthy, Stephen R. Spellman, Theresa E. Hahn, Benjamin G. Vincent, Paul M. Armistead, Lara E. Sucheston-Campbell

Blood (2022) 140 (Supplement 1): 668–670.

https://doi.org/10.1182/blood-2022-167165

Published: 2022

Journal Articles

Abrogation of Immune Effector Cell Neurotoxicity Syndrome (ICANS) By Rimiducid (RIM) in Patients Treated with CD19-Specific Chimeric Antigen Receptor Modified T-Cells (CAR-T) Engineered with an Inducible Caspase 9 (iC9 CAR.19)-Clinical and Pharmacodynamic Correlates

Matthew C. Foster, Barbara Savoldo, Winnie Lau, Clio Rubinos, Natalie S. Grover, Paul M. Armistead, James M. Coghill, Jr., Katarzyna Joanna Jamieson, Robert Hagan, J. Kaitlin Morrison, Faith Brianne Buchanan, Catherine Joyce Arago Cheng, Anastasia Ivanova, Tammy Cavallo, John West, Megan Gonzalez, Jonathan S. Serody, Gianpietro Dotti

Blood (2022) 140 (Supplement 1): 7437–7438.

https://doi.org/10.1182/blood-2022-165558

Published: 2022

Journal Articles

Shared Graft Versus Leukemia Minor Histocompatibility Antigens in DISCOVeRY-BMT

Blood (2022) 140 (Supplement 1): 4472–4474.

https://doi.org/10.1182/blood-2022-167018

Published: 2022

Journal Articles

Associations of Clinical Outcomes after Allogeneic Hematopoietic Cell Transplantation with Number of Predicted Class II Restricted mHA

Othmane Jadi, BS,BA, Hancong Tang, MS, Junke Wang, MS, Dante Bortone, PhD, Steven Vensko, PhD, Loreall Pooler, Xin Sheng, MS, Christopher A. Haiman, PhD, David Van Den Berg, PhD, Stephen R. Spellman, MS, Marcelo C. Pasquini, MDMS, Theresa E. Hahn, PhD, Paul M. Armistead, MD PhD, Benjamin G. Vincent, MD, Lara E. Sucheston-Campbell, PhDMS

Blood (2020) 136 (Supplement 1): 2.

https://doi.org/10.1182/blood-2020-142017

Published: 2020

Journal Articles

Population Distribution of GvL and GvH Minor Histocompatibility Antigens

Kelly Shea Olsen, MSc, Hancong Tang, MS, Junke Wang, MS, Sarah Entwistle, MSc, Dante S. Bortone, PhD, Steven Vensko, PhD, Loreall Pooler, Xin Sheng, MS, Christopher Haiman, David Van Den Berg, PhD, Stephen R. Spellman, MS, Theresa E. Hahn, PhD, Paul M. Armistead, MD PhD, Lara E. Sucheston-Campbell, PhDMS, Benjamin G. Vincent, MD

Blood (2020) 136 (Supplement 1): 23–25.

https://doi.org/10.1182/blood-2020-141120

Published: 2020

Journal Articles

Safety and Antitumor Effects of CD19-Specific Autologous Chimeric Antigen Receptor-Modified T (CAR-T) Cells Expressing the Inducible Caspase 9 Safety Switch (iC9-CAR19 T Cells) in Adult Acute Lymphoblastic Leukemia (ALL)

Matthew C Foster, MD, Philip A. Roehrs, MD, George E Hucks, MD, Natalie S Grover, MD, Paul M. Armistead, MD PhD, Katarzyna Jamieson, MD, Faith Brianne Buchanan, PA, J. Kaitlin C Morrison, PhD, Spencer Laing, BA, Catherine Joyce Arago Cheng, BS, Jonathan S. Serody, MD, Gianpietro Dotti, MD, Barbara Savoldo, MD PhD

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-139051

Published: 2020

Journal Articles

Detection of Measurable Residual Disease (MRD) in Peripheral Blood: First Report of a Novel Microfluidic Platform in Patients with Acute Myeloid Leukemia (AML)

Matthew C Foster, MD, Yuri Fedoriw, MD, Will Pulley, BA, Joshua Zeidner, MD, Catherine C. Coombs, MD, Emily Mirkin, Maryam Zomorrodi, Rachel Toughiri, PhD, Alena Bartakova, MD, Craig Carson, PhD, Rolf Muller, PhD, Paul M. Armistead, MD PhD

Blood (2019) 134 (Supplement_1): 1417.

https://doi.org/10.1182/blood-2019-127434

Published: 2019

Journal Articles

Identification of Leukemia Associated Minor Histocompatibility Antigens through Computational Prediction and Targeted Mass Spectrometry

Jefferson L. Lansford, BS, Udara Dharmasiri, PhD, Shengjie Chai, BS, Sally A. Hunsucker, PhD, Dante S. Bortone, PhD, James E. Keating, BS, Ian M. Schlup, Gary L. Glish, PhD, Edward J. Collins, PhD, Gheath Alatrash, DO, PhD, Jeffrey J. Molldrem, MD, Paul M. Armistead, MD PhD, Benjamin G. Vincent, MD

Blood (2017) 130 (Supplement 1): 207.

https://doi.org/10.1182/blood.V130.Suppl_1.207.207

Published: 2017

Journal Articles

Class I HLA Peptide Epitope Binding Efficiency Has No Impact on Graft Vs. Host Disease Incidence Following Allogeneic Hematopoietic Cell Transplantation

Charlotte McIlwaine Story, BS, MD, Jefferson L. Lansford, BS, Dominic T. Moore, MPH, MS, Chang Xu, Benjamin G. Vincent, MD, Paul M. Armistead, MD PhD, Marcie L. Riches, MDMS

Blood (2017) 130 (Supplement 1): 1987.

https://doi.org/10.1182/blood.V130.Suppl_1.1987.1987

Published: 2017

Journal Articles

Mechanism and Activity of ILC2 Cells Post Allo-BMT

Danny W Bruce, PhD, Heather E Stefanski, MD PhD, Benjamin G. Vincent, MD, Trisha Dant, BS, Shannon Reisdorf, BS, Hemamalini Bommiasamy, PhD, David Serody, Justin E Wilson, PhD, Karen McKinnon, PhD, Warren D Shlomchik, MD, Paul M. Armistead, MD PhD, Jenny PY Ting, PhD, John T Woosley, MD PhD, Dietmar MW Zaiss, PhD, Bruce R. Blazar, MD, Andrew NJ McKenzie, PhD, James Coghill, MD, Jonathan S. Serody, MD

Blood (2016) 128 (22): 1155.

https://doi.org/10.1182/blood.V128.22.1155.1155

Published: 2016

Journal Articles

Integrated In Silico Prediction of Minor Histocompatibility Antigen Peptides in HLA-Matched Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

Jefferson L. Lansford, Shengjie Chai, Gheath Alatrash, DO, PhD, Jeffrey J. Molldrem, MD, Paul M. Armistead, MD PhD, Benjamin G. Vincent, MD

Blood (2016) 128 (22): 3352.

https://doi.org/10.1182/blood.V128.22.3352.3352

Published: 2016

Journal Articles

Reduced Intensity Continuous Infusion Busulfan for Allogeneic Hematopoietic Cell Transplant Patients with Hematologic Disorders Who Are Ineligible or Inappropriate for Treatment with a More Intensive Therapeutic Regimen: LCCC 0306

Reed Friend, MD, James Xenakis, Jonathan S Serody, MD, Terrance Comeau, MD, Don A. Gabriel, MD PhD, Stefanie Sarantopoulos, MD PhD, James Coghill, MD, William A. Wood, MD MPH, Andrew Sharf, Julia S Whitley, BS, Kamakshi Rao, PharmD, Christine M Walko, PharmD,BCOP, Anastasia Ivanova, PhD, Thomas C. Shea, MD, Paul M Armistead, MD PhD

Blood (2015) 126 (23): 3117.

https://doi.org/10.1182/blood.V126.23.3117.3117

Published: 2015

Journal Articles

Rapid Assessment of Minimal Residual Acute Myeloid Leukemia from Peripheral Blood Using a Microfluidic Chip

Joshua M. Jackson, MS, James Taylor, BS, Malgorzata Witek, PhD, Sally A. Hunsucker, PhD, Jennifer Paulsen Waugh, MD, Yuri D. Fedoriw, MD, Thomas C. Shea, MD, Steven A. Soper, PhD, Paul M. Armistead, MD PhD

Blood (2015) 126 (23): 1389.

https://doi.org/10.1182/blood.V126.23.1389.1389

Published: 2015

Journal Articles

Interval Exercise Training (IET) Is Feasible and May Improve Cardiorespiratory Performance Prior to Hematopoietic Cell Transplantation

Mathew Meeneghan, MD, Anna Snavely, PhD, Abbie Smith-Ryan, PhD, Claudio L Battaglini, PhD, Bryce B Reeve, PhD, Ethan Basch, MD MSc, Antonia Bennett, PhD, Charlotte Shatten, MA, Brett Phillips, BS, Jonathan Serody, MD, PhD, Don A. Gabriel, MD PhD, Katarzyna Joanna Jamieson, MD, James Coghill, MD, Paul M. Armistead, MD PhD, Thomas C. Shea, MD, William A. Wood, MD MPH

Blood (2014) 124 (21): 2611.

https://doi.org/10.1182/blood.V124.21.2611.2611

Published: 2014

Journal Articles

UNC-GRK4-1: An Allele Specific Cancer Testis Antigen Identified Through Genomic Screening

Udara Dharamsiri, PhD, Sally A. Hunsucker, PhD, Benjamin G. Vincent, MD, Michael Wu, PhD, Edward J. Collins, PhD, Shoudan Liang, PhD, Jeffrey J. Molldrem, MD, Paul M. Armistead, MD, PhD

Blood (2013) 122 (21): 3246.

https://doi.org/10.1182/blood.V122.21.3246.3246

Published: 2013

Journal Articles

BCR Hyper-Responsiveness In B Cells From Patients With Chronic Gvhd Is Blocked With The Syk Inhibitor R406

Blood (2013) 122 (21): 910.

https://doi.org/10.1182/blood.V122.21.910.910

Published: 2013

Journal Articles

Feasibility of Daily and Weekly Symptom and Health-Related Quality of Life (HRQOL) Surveillance in Patients Receiving Hematopoietic Cell Transplantation (HCT)

William A Wood, MD, MPH, Allison M Deal, MS, Bryce B Reeve, PhD, Amy P Abernethy, MD, Claudio L Battaglini, PhD, Yoon Hie Kim, BS, Julia S Whitley, BS, Charlotte Shatten, BS, Robert N Irons, PA, Amber N Essenmacher, PA, Kimberly Wehner, PA, Alicia Pinto, PA, James Coghill, MD, Paul M Armistead, MD, PhD, Stefanie Sarantopoulos, MD, PhD, Don A. Gabriel, MD, PhD, Jonathan S Serody, MD, Thomas C. Shea, MD

Blood (2012) 120 (21): 4471.

https://doi.org/10.1182/blood.V120.21.4471.4471

Published: 2012

Journal Articles

Mer Receptor Tyrosine Kinase Is A Potential Therapeutic Target in Acute Myeloid Leukemia

Alisa B. Lee-Sherick, MD, Kelly Menachof, Kristen M. Eisenman, MD, Amy McGranahan, Colleen McGary, Sally A. Hunsucker, PhD, Jennifer Schlegel, Paul M Armistead, MD, PhD, Xiayuan Liang, MD, Dmitri Kireev, William Janzen, Jing Liu, Michael Stashko, Jacqueline Norris-Drouin, H. Shelton Earp, III, Xiaodong Wang, Stephen Frye, Deborah DeRyckere, PhD, Douglas K. Graham, MD, PhD

Blood (2012) 120 (21): 1317.

https://doi.org/10.1182/blood.V120.21.1317.1317

Published: 2012

Journal Articles

Feasibility and Prognostic Value of VO2 peak in Patients Undergoing Hematopoietic Cell Transplantation (HCT)

William A Wood, MD, MPH, Allison M Deal, MS, Claudio L Battaglini, PhD, Bryce B Reeve, PhD, Amy P Abernethy, MD, Yoon Hie Kim, BS, Julia S Whitley, BS, Charlotte Shatten, BS, Robert N Irons, PA, Amber N Essenmacher, PA, Kimberly Wehner, PA, Alicia Pinto, PA, James Coghill, MD, Paul M Armistead, MD, PhD, Stefanie Sarantopoulos, MD, PhD, Don A. Gabriel, MD, PhD, Jonathan S Serody, MD, Thomas C. Shea, MD

Blood (2012) 120 (21): 4152.

https://doi.org/10.1182/blood.V120.21.4152.4152

Published: 2012

NARROW

Development of a mRNA Lipid Nanoparticle (mRNA-LNP) Cancer Vaccine to Prevent Leukemia Relapse after Stem Cell Transplant

Associations of Minor Histocompatibility Antigens with Clinical Outcomes Following Allogeneic Hematopoietic Cell Transplantation

Abrogation of Immune Effector Cell Neurotoxicity Syndrome (ICANS) By Rimiducid (RIM) in Patients Treated with CD19-Specific Chimeric Antigen Receptor Modified T-Cells (CAR-T) Engineered with an Inducible Caspase 9 (iC9 CAR.19)-Clinical and Pharmacodynamic Correlates

Shared Graft Versus Leukemia Minor Histocompatibility Antigens in DISCOVeRY-BMT

Associations of Clinical Outcomes after Allogeneic Hematopoietic Cell Transplantation with Number of Predicted Class II Restricted mHA

Population Distribution of GvL and GvH Minor Histocompatibility Antigens

Safety and Antitumor Effects of CD19-Specific Autologous Chimeric Antigen Receptor-Modified T (CAR-T) Cells Expressing the Inducible Caspase 9 Safety Switch (iC9-CAR19 T Cells) in Adult Acute Lymphoblastic Leukemia (ALL)

Detection of Measurable Residual Disease (MRD) in Peripheral Blood: First Report of a Novel Microfluidic Platform in Patients with Acute Myeloid Leukemia (AML)

Identification of Leukemia Associated Minor Histocompatibility Antigens through Computational Prediction and Targeted Mass Spectrometry

Class I HLA Peptide Epitope Binding Efficiency Has No Impact on Graft Vs. Host Disease Incidence Following Allogeneic Hematopoietic Cell Transplantation

Mechanism and Activity of ILC2 Cells Post Allo-BMT

Integrated In Silico Prediction of Minor Histocompatibility Antigen Peptides in HLA-Matched Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

Reduced Intensity Continuous Infusion Busulfan for Allogeneic Hematopoietic Cell Transplant Patients with Hematologic Disorders Who Are Ineligible or Inappropriate for Treatment with a More Intensive Therapeutic Regimen: LCCC 0306

Rapid Assessment of Minimal Residual Acute Myeloid Leukemia from Peripheral Blood Using a Microfluidic Chip

Interval Exercise Training (IET) Is Feasible and May Improve Cardiorespiratory Performance Prior to Hematopoietic Cell Transplantation

UNC-GRK4-1: An Allele Specific Cancer Testis Antigen Identified Through Genomic Screening

BCR Hyper-Responsiveness In B Cells From Patients With Chronic Gvhd Is Blocked With The Syk Inhibitor R406

Feasibility of Daily and Weekly Symptom and Health-Related Quality of Life (HRQOL) Surveillance in Patients Receiving Hematopoietic Cell Transplantation (HCT)

Mer Receptor Tyrosine Kinase Is A Potential Therapeutic Target in Acute Myeloid Leukemia

Feasibility and Prognostic Value of VO2 peak in Patients Undergoing Hematopoietic Cell Transplantation (HCT)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only